Tanya Sharma – Marketsandmarkets™
View Detailed Executive Profile →Professional Overview
- Tanya Sharma is currently a Strategy Consultant in the Pharma and Healthcare sector at MarketsandMarkets™, effective from February 1, 2024, focusing on solving complex problems to create impactful solutions in the healthcare industry.
- Previously held the position of Senior Associate in Pharma Strategy Consulting at ZS from December 2022 until February 2024, contributing to strategic initiatives aimed at enhancing healthcare delivery.
- Started as an Associate at ZS in October 2021, rapidly advancing to Senior Associate by demonstrating proficiency in developing pharma strategy solutions.
- Worked at Dr. Reddy's Laboratories as a Drug Development Scientist from August 2020 to December 2020, where responsibilities included conducting research and development of pharmaceutical products.
- Pursued a role as a Senior Scientist at Dr. Reddy's Laboratories from August 2020 to October 2021, enhancing product development processes through scientific innovation.
- Founded Medwarriers in May 2020, an initiative focused on leveraging medical technologies to improve healthcare accessibility and education.
- Served as a Product/Market Development Specialist at Dr Best from March 2019 to August 2019, aiding in the development of market strategies for medical products.
- Acted as a Research Scholar at the University Institute of Pharmaceutical Sciences, Panjab University from August 2018 to August 2020, contributing to academic research in pharmaceutical sciences.
- Gained hands-on experience as a Trainee Pharmacist at J.N Shoree Multispeciality Hospital from June 2018 to August 2018, providing practical insights into pharmacy operations.
- Embarked on an internship with Cipla in June 2017 in QA/QC/Production, gaining foundational industry experience in pharmaceutical quality assurance and production processes.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| ZS | Associate - Pharma Strategy Consulting | Oct 2021 – Dec 2022 |
| Medwarriers | Founder | May 2020 – Dec 2022 |
| Dr Best | Product/Market Development Specialist | Mar 2019 – Aug 2019 |
| J.N Shoree Multispeciality Hospital | Trainee Pharmacist | Jun 2018 – Aug 2018 |
| Cipla | QA/QC/Production Intern | Jun 2017 – Jul 2017 |
| ZS | Senior Associate - Pharma Strategy Consulting | Dec 2022 – Feb 2024 |
| Dr. Reddy's Laboratories | Drug Development Scientist | Aug 2020 – Dec 2020 |
| Dr. Reddy's Laboratories | Senior Scientist | Aug 2020 – Oct 2021 |
| University Institute of Pharmaceutical Sciences (UIPS), Panjab University | Research Scholar | Aug 2018 – Aug 2020 |
| MarketsandMarkets™ | Strategy Consultant- Pharma & Healthcare💊💉|| Solving complex problems to create Impact in Healthcare Industry🌟 || Founder @Medwarriers || Ex Scientist @ Dr.Reddys || Ex Consultant | Feb 2024 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Marketsandmarkets™ corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Tanya Sharma's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Marketsandmarkets™'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)